 This article contains a selection of scientific highlights in the field of interstitial lung diseases, ILDs, presented at the Hybrid European Respiratory Society International Congress 2022. Early career members of Assembly 12 summarized recent advances in translational and clinical research in idiopathic interstitial pneumonias, ILDs of known origin, succoidosis, and other granulometous diseases, and rare ILDs. Many studies focused on evaluation of diagnostic and prognostic, bio, markers, and novel pharmacological and non-pharmacological treatment options for different ILDs. In addition, new insights in clinical, physiological, and radiological features of various rare ILDs were presented. This article was authored by Theodoras Karampitzikos, Form Form Deep, Dan W. Loat and others.